Search Results - "Maschke, S"

The free plasma amyloid Aβ1–42/Aβ1–40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ1–42/Aβ1–40 ratio. The BALTAZAR study by Schraen-Maschke, S., Duhamel, A., Vidal, J.S., Ramdane, N., Vaudran, L., Dussart, C., Buée, L., Sablonnière, B., Delaby, C., Allinquant, B., Gabelle, A., Bombois, S., Lehmann, S., Hanon, O.

“…Blood-based biomarkers are a non-invasive solution to predict the risk of conversion of mild cognitive impairment (MCI) to dementia. The utility of free plasma…”
Get full text

The free plasma amyloid Aβ 1 - 42 /Aβ 1 - 40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ 1 - 42 /Aβ 1 - 40 ratio. The BALTAZAR study by Schraen-Maschke, S, Duhamel, A, Vidal, J S, Ramdane, N, Vaudran, L, Dussart, C, Buée, L, Sablonnière, B, Delaby, C, Allinquant, B, Gabelle, A, Bombois, S, Lehmann, S, Hanon, O

“…Blood-based biomarkers are a non-invasive solution to predict the risk of conversion of mild cognitive impairment (MCI) to dementia. The utility of free plasma…”
Get full text

Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness by Meine, T. C., Becker, L. S., Dewald, C. L. A., Maschke, S. K., Maasoumy, B., Jaeckel, E., Wedemeyer, H., Wacker, F. K., Meyer, B. C., Hinrichs, J. B.

“…Purpose To assess the feasibility, safety and effectiveness of portal vein recanalization (PVR)–transjugular portosystemic shunt (TIPS) placement via splenic…”
Get full text

Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery by Dewald, C. L. A., Becker, L. S., Maschke, S. K., Meine, T. C., Alten, T. A., Kirstein, M. M., Vogel, A., Wacker, F. K., Meyer, B. C., Hinrichs, J. B.

“…To evaluate feasibility, frequency and severity of peri-procedural complications and post-procedural adverse events (AEs) in patients with advanced…”
Get full text

Regulatory T Cells Promote Natural Killer Cell Education in Mixed Chimeras by Mahr, B., Pilat, N., Maschke, S., Granofszky, N., Schwarz, C., Unger, L., Hock, K., Farkas, A. M., Klaus, C., Regele, H., Wekerle, T.

“…Therapeutic administration of regulatory T cells (Tregs) leads to engraftment of conventional doses of allogeneic bone marrow (BM) in nonirradiated recipient…”
Get full text

Adrenal venous sampling in primary hyperaldosteronism: correlation of hormone indices and collimated C-arm CT findings by Becker, L. S., Hinrichs, M. H., Werncke, T., Dewald, C. L. A., Maschke, S. K., Limbourg, F. P., Ringe, K. I., Hinrichs, J. B., Wacker, F., Meyer, B. C.

“…Purpose To evaluate the feasibility and effect of an approach to adrenal venous sampling (AVS) analysis by combining established selective cortisol and…”
Get full text

Association of plasma amyloid β with risk of dementia: The prospective Three-City Study by LAMBERT, J.-C, SCHRAEN-MASCHKE, S, AMOUYEL, P, RICHARD, F, FIEVET, N, ROUAUD, O, BERR, C, DARTIGUES, J.-F, TZOURIO, C, ALPEROVITCH, A, BUEE, L

“…Several lines of evidence indicate that a decrease in the CSF concentration of amyloid beta(42) (Abeta(42)) is a potential biomarker for incident Alzheimer…”
Get full text

Two-dimensional parametric parenchymal blood flow in transarterial chemoembolisation for hepatocellular carcinoma: perfusion change quantification and tumour response prediction at 3 months post-intervention by Becker, L.S., Maschke, S.K., Dewald, C.L.A., Meine, T.C., Winther, H.B.M., Kirstein, M.M., Kloeckner, R., Meyer, B.C., Wacker, F., Hinrichs, J.B.

“…To evaluate the feasibility and potential value of two-dimensional (2D) parametric parenchymal blood flow (2D-PPBF) for the assessment of perfusion changes…”
Get full text

Virtual single source CT using dual source acquisition: Clinical applicability in run-off CT-angiography for intra-individual comparison of different scan protocols by Werncke, T., Hinrichs, J.B., Alikhani, B., Maschke, S., Wacker, F.K., Meyer, B.C.

“…[Display omitted] •Virtual single Source CT (VSS-CT) is feasible in clinical routine.•VSS-CT enables the dose-neutral intra-individual comparison of…”
Get full text

Evaluation of a newly developed 2D parametric parenchymal blood flow technique with an automated vessel suppression algorithm in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty by Maschke, S.K., Winther, H.M.B., Meine, T., Werncke, T., Olsson, K.M., Hoeper, M.M., Baumgart, J., Wacker, F.K., Meyer, B.C., Renne, J., Hinrichs, J.B.

“…To evaluate the feasibility of two-dimensional parametric parenchymal blood flow (2D-PPBF) to quantify perfusion changes in the lung parenchyma following…”
Get full text

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2 by Carpentier, C., Ghanem, D., Fernandez-Gomez, F.J., Jumeau, F., Philippe, J.V., Freyermuth, F., Labudeck, A., Eddarkaoui, S., Dhaenens, C.M., Holt, I., Behm-Ansmant, I., Marmier-Gourrier, N., Branlant, C., Charlet-Berguerand, N., Marie, J., Schraen-Maschke, S., Buée, L., Sergeant, N., Caillet-Boudin, M.L.

“…The splicing of the microtubule-associated protein Tau is regulated during development and is found to be deregulated in a growing number of pathological…”
Get full text

Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing by Dhaenens, C.M., Tran, H., Frandemiche, M.-L., Carpentier, C., Schraen-Maschke, S., Sistiaga, A., Goicoechea, M., Eddarkaoui, S., Van Brussels, E., Obriot, H., Labudeck, A., Gevaert, M.H., Fernandez-Gomez, F., Charlet-Berguerand, N., Deramecourt, V., Maurage, C.A., Buée, L., de Munain, A. Lopez, Sablonnière, B., Caillet-Boudin, M.L., Sergeant, N.

“…Tau is the proteinaceous component of intraneuronal aggregates common to neurodegenerative diseases called Tauopathies, including myotonic dystrophy type 1. In…”
Get full text

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats by Dhaenens, C.M., Schraen-Maschke, S., Tran, H., Vingtdeux, V., Ghanem, D., Leroy, O., Delplanque, J., Vanbrussel, E., Delacourte, A., Vermersch, P., Maurage, C.A., Gruffat, H., Sergeant, A., Mahadevan, M.S., Ishiura, S., Buée, L., Cooper, T.A., Caillet-Boudin, M.L., Charlet-Berguerand, N., Sablonnière, B., Sergeant, N.

“…Neurofibrillary degeneration is often observed in the brain of patients with type 1 myotonic dystrophy (DM1). It consists principally of the aggregation of Tau…”
Get full text

Clinical features and genetic analysis of a new form of spinocerebellar ataxia by DEVOS, D, SCHRAEN-MASCHKE, S, VUILLAUME, I, DUJARDIN, K, NAZE, P, WILLOTEAUX, C, DESTEE, A, SABLONNIERE, B

“…The autosomal dominant cerebellar ataxias (ADCA) are a clinically heterogeneous group of disorders. The mutations for SCA1, SCA2, SCA3, SCA6, SCA7, SCA8, and…”
Get full text

P18 Variant triplet repeats in the CTG expansion of DMPK affect stability of the expanded region and may contribute to unusual symptoms observed in some myotonic dystrophy type 1 cases by Braida, C, Stapleton, G, Neil, F, Rhadvanyi, H, Philippe, C, Finsterer, J, Schraen-Maschke, S, Gallano, P, Warner, J, Longman, C, Hilton-Jones, D, Brunner, H, Kamsteeg, E.-J, Berland, S, Catalli, C, Botta, A, Monckton, D.G

Get full text

Role of oligomannosidic N-glycans in the proliferation, adhesion and signalling of C6 glioblastoma cells by Schraen-Maschke, S., Zanetta, J.-P.

“…The potential role of glycoprotein N-glycans in the proliferation and adhesion of C6 glioblastoma cells was investigated using a set of N-glycosylation…”
Get full text

Abstract No. 182 Evaluation of adjunctive collimated C-arm computed tomography in adrenal venous sampling and its effect on successful selective catheterization by Becker, L., Hinrichs, M., Werncke, T., Maschke, S., Limbourg, F., Ringe, K.I., Hinrichs, J., Wacker, F., Meyer, B.

Get full text

Abstract No. 481 Chemosaturation with percutaneous hepatic perfusion in patients with metastasized uveal melanoma: assessment of therapy outcome and safety by Dewald, C., Becker, L., Maschke, S., Meine, T., Hinrichs, J., Meyer, B., Vogel, A., Schönfeld, L., Kirstein, M., Wacker, F.

Get full text

Absence of unidentified CAG repeat expansion in patients with Huntington's disease-like phenotype by Vuillaume, I, Meynieu, P, Schraen-Maschke, S, Destée, A, Sablonnière, B

“…Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an expanded (CAG)n repeat on the huntingtin gene. It is characterised…”
Get full text

4:21 PM Abstract No. 61 Transjugular intrahepatic portosystemic shunt creation: guidance of portal vein puncture by use of three-dimensional–two-dimensional fusion of conventional multidetector-computed-tomography and fluoroscopy by Meine, T., Werncke, T., Kirstein, M., Maschke, S., Dewald, C., Becker, L., Wacker, F., Meyer, B., Hinrichs, J.

Get full text